Not Signed In -
Atomoxetine |
Strattera |
Atomoxetine Systematic (IUPAC) name (3S)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine Identifiers CAS number 82248-59-7 ATC code N06BA09 PubChem 54841 DrugBank APRD00614 Chemical data Formula C17H21NO·HCl Mol. weight 291.82 (255.355 without HCl) Pharmacokinetic data Bioavailability ? Metabolism Hepatic, via CYP2D6 Half life 5 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Unscheduled Routes Oral ...
Wikipedia - [full article]
Atomoxetine Clinical Trials
- Atomoxetine as and Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
ClinicalTrials.gov Identifier: NCT00161031 - Active, not recruiting
Schizophrenia
- Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
ClinicalTrials.gov Identifier: NCT00174226 - Completed
Attention Deficit Disorder With Hyperactivity
- Long-Term, Open Label Atomoxetine Study
ClinicalTrials.gov Identifier: NCT00190684 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of ADHD
ClinicalTrials.gov Identifier: NCT00191945 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
ClinicalTrials.gov Identifier: NCT00265265 - Active, not recruiting
Cocaine-Related Disorders
- Atomoxetine and Huntington's Disease
ClinicalTrials.gov Identifier: NCT00368849 - Active, not recruiting
Huntington Disease; Chorea
- Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
ClinicalTrials.gov Identifier: NCT00191698 - Active, not recruiting
Attention-Deficit/Hyperactivity Disorder; Oppositional Defiant Disorder
- Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects
ClinicalTrials.gov Identifier: NCT00255138 - Not yet recruiting
Cancer; Cognitive Late Effects
- Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
ClinicalTrials.gov Identifier: NCT00176436 - Recruiting
Schizophrenia
- Atomoxetine Pilot Study in Preschool Children With ADHD
ClinicalTrials.gov Identifier: NCT00517647 - Recruiting
Attention Deficit Hyperactivity Disorder
- Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD
ClinicalTrials.gov Identifier: NCT00529893 - Recruiting
Attention Deficit Disorder With Hyperactivity
- Comparison of Atomoxetine Versus Placebo in Children With ADHD
ClinicalTrials.gov Identifier: NCT00546910 - Recruiting
Attention Deficit Hyperactivity Disorder
- Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL
ClinicalTrials.gov Identifier: NCT00299234 - Recruiting
Attention Deficit Hyperactivity Disorder
- Treatment of ADHD With Atomoxetine in Young Adults and Its Effects on Functional Outcomes
ClinicalTrials.gov Identifier: NCT00510276 - Recruiting
Attention Deficit/Hyperactivity Disorder
- A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With ADHD
ClinicalTrials.gov Identifier: NCT00190775 - Recruiting
Attention Deficit Hyperactivity Disorder
- Atomoxetine Treatment for ADHD and Marijuana Dependence
ClinicalTrials.gov Identifier: NCT00360269 - Recruiting
Marijuana Abuse; Attention Deficit Disorder With Hyperactivity
- Atomoxetine for the Treatment of Cannabis Dependence
ClinicalTrials.gov Identifier: NCT00167297 - Active, not recruiting
Cannabis Dependence
- Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
ClinicalTrials.gov Identifier: NCT00191386 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Effectiveness of Atomoxetine in Treating Attention Deficit Hyperactivity Disorder Symptoms in Children and Adolescents With Autism
ClinicalTrials.gov Identifier: NCT00498173 - Recruiting
Autism
- Atomoxetine Phase 2 Study in Japanese Adult Patients With ADHD
ClinicalTrials.gov Identifier: NCT00530335 - Recruiting
Attention Deficit/Hyperactivity Disorder(ADHD)
- The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00566371 - Recruiting
Attention Deficit Hyperactivity Disorder; Insomnia
- Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany
ClinicalTrials.gov Identifier: NCT00406354 - Recruiting
Attention Deficit Hyperactivity Disorder; Oppositional Defiant Disorder
- Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov Identifier: NCT00218543 - Active, not recruiting
Attention Deficit Disorder With Hyperactivity; Cocaine-Related Disorders
- A Study Comparing the Effect of Atomoxetine vs Other Standard Care Therapy on the Long Term Functioning in ADHD Children and Adolescents
ClinicalTrials.gov Identifier: NCT00447278 - Recruiting
Attention Deficit/Hyperactivity Disorder (ADHD)
- Atomoxetine Versus Placebo for Symptoms of ADHD in Children and Adolescents With Autism Spectrum Disorder
ClinicalTrials.gov Identifier: NCT00380692 - Recruiting
Autistic Disorder; Attention Deficit Disorder With Hyperactivity
- Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00252278 - Recruiting
Attention-Deficit/Hyperactivity Disorder (ADHD); Insomnia
- Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype
ClinicalTrials.gov Identifier: NCT00548327 - Recruiting
Schizophrenia; Working Memory; Cognition; Healthy Volunteers
- An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder.
ClinicalTrials.gov Identifier: NCT00192023 - Active, not recruiting
Attention-Deficit/Hyperactivity Disorder; Oppositional Defiant Disorder
- Comparison of Atomoxetine and Placebo in Children With ADHD and/or Reading Disorder
ClinicalTrials.gov Identifier: NCT00191906 - Recruiting
Attention-Deficit/Hyperactivity Disorder; Reading Disorder
- Effectiveness of Atomoxetine in Treating Marijuana Dependent Individuals Diagnosed With Attention Deficit Hyperactivity Disorder - 1
ClinicalTrials.gov Identifier: NCT00227851 - Recruiting
Atention Deficit Disorder With Hyperactivity; Marijuana Abuse
- Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00260533 - Recruiting
Generalized Social Anxiety Disorder
- Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00320528 - Recruiting
Attention Deficit Disorder With Hyperactivity
- Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
ClinicalTrials.gov Identifier: NCT00418262 - Recruiting
Fetal Alcohol Syndrome; Attention Deficit Disorder (ADD); Attention Deficit Disorder With Hyperactivity (ADHD)
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00568685 - Recruiting
Attention Deficit Hyperactivity Disorder
- Effectiveness of Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder (ADHD) - 1
ClinicalTrials.gov Identifier: NCT00142961 - Active, not recruiting
Attention Deficit Disorder with Hyperactivity; Marijuana Abuse
- Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
ClinicalTrials.gov Identifier: NCT00254462 - Recruiting
Attention Deficit Disorder With Hyperactivity
- A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
ClinicalTrials.gov Identifier: NCT00471354 - Recruiting
Attention Deficit Disorder With Hyperactivity
- Effectiveness of Atomoxetine in Treating Adolescents With Attention Deficit Hyperactivity Disorder and Substance Use Disorder
ClinicalTrials.gov Identifier: NCT00218322 - Recruiting
Attention Deficit Disorder With Hyperactivity; Substance-Related Disorders
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
ClinicalTrials.gov Identifier: NCT00417794 - Recruiting
Fetal Alcohol Syndrome; Attention Deficit Disorder With Hyperactivity (ADHD); Attention Deficit Disorder (ADD)
- Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
ClinicalTrials.gov Identifier: NCT00399763 - Recruiting
Attention Deficit Hyperactivity Disorder; Substance Use Disorder
- Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD
ClinicalTrials.gov Identifier: NCT00191035 - Completed
Attention-Deficit/Hyperactivity Disorder
- Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents
ClinicalTrials.gov Identifier: NCT00191542 - Completed
Attention Deficit Hyperactivity Disorder
- Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD
ClinicalTrials.gov Identifier: NCT00486083 - Completed
Attention Deficit Hyperactivity Disorder
- Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD
ClinicalTrials.gov Identifier: NCT00191048 - Completed
Attention-Deficit/Hyperactivity Disorder; Comorbid Dyslexia
- Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents
ClinicalTrials.gov Identifier: NCT00191659 - Completed
Attention Deficit Hyperactivity Disorder
- Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes
ClinicalTrials.gov Identifier: NCT00191633 - Completed
Attention-Deficit/Hyperactivity Disorder
- Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD
ClinicalTrials.gov Identifier: NCT00485459 - Completed
Attention Deficit Hyperactivity Disorder
- Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
ClinicalTrials.gov Identifier: NCT00485407 - Completed
Attention Deficit Hyperactivity Disorder
- Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy
ClinicalTrials.gov Identifier: NCT00485550 - Completed
Attention Deficit Hyperactivity Disorder
- Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD
ClinicalTrials.gov Identifier: NCT00485875 - Completed
Attention Deficit Hyperactivity Disorder
- Effects of Atomoxetine on Cognitive Function in Schizophrenia
ClinicalTrials.gov Identifier: NCT00420498 - Completed
Schizophrenia; Cognition; Smoking
- Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00488163 - Completed
Schizophrenia
- Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00191009 - Completed
Alzheimer Disease
- Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients with Chronic Resistant Schizophrenia
ClinicalTrials.gov Identifier: NCT00216281 - Terminated
Schizophrenia
- Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)
ClinicalTrials.gov Identifier: NCT00190736 - Completed
ADHD
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00222794 - Completed
Schizophrenia; Schizoaffective Disorder
- A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
ClinicalTrials.gov Identifier: NCT00485849 - Completed
Attention Deficit Hyperactivity Disorder
- ADDERALL XR (Mixed Salts of a Single-Entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
ClinicalTrials.gov Identifier: NCT00557960 - Completed
Attention Deficit Disorder With Hyperactivity
- Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00191880 - Completed
Attention Deficit Hyperactivity Disorder
- Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00386581 - Completed
Attention Deficit Disorder With Hyperactivity
- A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00190931 - Completed
Attention Deficit Disorder With Hyperactivity
- Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00190879 - Completed
Attention Deficit Hyperactivity Disorder; Comorbid Social Anxiety Disorder
- Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov Identifier: NCT00191295 - Completed
Attention Deficit Hyperactivity Disorder
- An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00191516 - Completed
Attention Deficit Hyperactivity Disorder
- An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00191737 - Completed
Attention Deficit Hyperactivity Disorder
- Atomoxetine in the Treatment of Binge Eating Disorder
ClinicalTrials.gov Identifier: NCT00327834 - Completed
Binge-Eating Disorder
- Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse
ClinicalTrials.gov Identifier: NCT00190957 - Completed
ADHD; Comorbid Alcohol Abuse
- Neuropsychological Functioning in Children with Attention-Deficit/Hyperactivity Disorder.
ClinicalTrials.gov Identifier: NCT00216918 - Completed
Attention Deficit Hyperactivity Disorder
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
ClinicalTrials.gov Identifier: NCT00562055 - Terminated
Attention Deficit Hyperactivity Disorder
Resources
- Atomoxetine (Drug Digest)
- Strattera (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
